LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
655
via finance.yahoo.comBusiness & Companies

Johnson & Johnson in Advanced Talks to Buy Ollin Biosciences

FROM THE WIRE · FINANCE.YAHOO.COM

Johnson & Johnson (JNJ) is back in focus after reports it is in advanced talks to buy eye drug developer Ollin Biosciences in a deal valued at up to US$3.4b. The Ollin Biosciences headlines land on top of a strong run for Johnson & Johnson, with the share price at US$285.75 and…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralA deal valued at up to $3.4 billion is relevant for pharma but has limited impact on the large group.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01According to reports, J&J is in advanced talks to buy Ollin Biosciences.
  2. 02The deal is valued at up to $3.4 billion.
  3. 03The share price is $285.75 with a 37.81% year-to-date gain.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.